Robert Lauter v. FDA
| ROBERT LAUTER |
| GLAXOSMITHKLINE, COMMONWEALTH OF VIRGINIA and UNITED STATES FOOD AND DRUG ADMINISTRATION |
| 20-1203 |
| February 25, 2020 |
| U.S. Court of Appeals, Fourth Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 26, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 INFORMAL RESPONSE BRIEF by GlaxoSmithKline. [20-1203] Richard Cromwell [Entered: 03/26/2020 03:59 PM] |
| Filing 6 DISCLOSURE STATEMENT by GlaxoSmithKline. Was any question on Disclosure Form answered yes? Yes [1000710086] [20-1203] Richard Cromwell [Entered: 03/26/2020 02:49 PM] |
| Filing 5 APPEARANCE OF COUNSEL by Richard Cromwell for GlaxoSmithKline. [1000710055] [20-1203] Richard Cromwell [Entered: 03/26/2020 02:21 PM] |
| Filing 4 INFORMAL OPENING BRIEF by Robert Lauter. [20-1203] RE [Entered: 03/17/2020 09:53 AM] |
| Filing 3 ASSEMBLED ELECTRONIC RECORD docketed. Originating case number: 2:19-cv-00157-AWA-RJK. Record in folder? Yes. Record reviewed? Yes. PSR included? N/A. [20-1203] RE [Entered: 02/25/2020 10:42 AM] |
| Filing 2 INFORMAL BRIEFING ORDER filed. Mailed to: Robert Lauter. Informal Opening Brief due 03/20/2020. Informal response brief, if any: 14 days after informal opening brief served. [20-1203] RE [Entered: 02/25/2020 10:39 AM] |
| Filing 1 Case docketed. Originating case number: 2:19-cv-00157-AWA-RJK. Case manager: REdwards. [20-1203] RE [Entered: 02/25/2020 10:38 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
